Clinical Trial Update: Amping up With PemJAK [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of PemJAK for multiple lymphoma subtypes is currently recruiting, including non-Hodgkin lymphoma and Hodgkin lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma
• Gray Zone Lymphoma
• Hodgkin Lymphoma
• Mediastinal B-cell Lymphoma
• Non-hodgkin Lymphoma
• Peripheral T-cell Lymphoma

Drugs mentioned

• PemJAK

Snippet

Sponsor: Seda S. Tolu | Conditions: Non-Hodgkin Lymphoma, Hodgkin Disease Lymphoma | Phase 2 | Status: RECRUITING